Mustang Bio, Inc. (MBIO)
0.37
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
Mustang Bio Price to Book Value : 0.3716 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.3716 |
| October 22, 2026 | 0.3708 |
| October 21, 2026 | 0.3845 |
| October 20, 2026 | 0.3811 |
| October 19, 2026 | 0.3746 |
| October 16, 2026 | 0.378 |
| October 15, 2026 | 0.3878 |
| October 14, 2026 | 0.3717 |
| October 13, 2026 | 0.3784 |
| October 12, 2026 | 0.4142 |
| October 09, 2026 | 0.4018 |
| October 08, 2026 | 0.4188 |
| October 07, 2026 | 0.4521 |
| October 06, 2026 | 0.462 |
| October 05, 2026 | 0.4621 |
| October 02, 2026 | 0.4731 |
| October 01, 2026 | 0.4692 |
| September 30, 2026 | 0.465 |
| September 29, 2026 | 0.4817 |
| September 28, 2026 | 0.5091 |
| September 25, 2026 | 0.5226 |
| September 24, 2026 | 0.5285 |
| September 23, 2026 | 0.5136 |
| September 22, 2026 | 0.5333 |
| September 21, 2026 | 0.5524 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.542 |
| September 17, 2026 | 0.4922 |
| September 16, 2026 | 0.5022 |
| September 15, 2026 | 0.5057 |
| September 14, 2026 | 0.5123 |
| September 11, 2026 | 0.5094 |
| September 10, 2026 | 0.5222 |
| September 09, 2026 | 0.5304 |
| September 08, 2026 | 0.5435 |
| September 04, 2026 | 0.5452 |
| September 03, 2026 | 0.5624 |
| September 02, 2026 | 0.5453 |
| September 01, 2026 | 0.5505 |
| August 31, 2026 | 0.5398 |
| August 28, 2026 | 0.5399 |
| August 27, 2026 | 0.5525 |
| August 26, 2026 | 0.5624 |
| August 25, 2026 | 0.5544 |
| August 24, 2026 | 0.5537 |
| August 21, 2026 | 0.5812 |
| August 20, 2026 | 0.5754 |
| August 19, 2026 | 0.5765 |
| August 18, 2026 | 0.5725 |
| August 17, 2026 | 0.5969 |
| August 14, 2026 | 0.5961 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| Price | 0.37 |
| Earnings Yield | -121.6% |
| Market Cap | 2.804M |